Literature DB >> 12718895

XRCC3 and Rad51 modulate replication fork progression on damaged vertebrate chromosomes.

Judith Henry-Mowatt1, Dean Jackson, Jean-Yves Masson, Penny A Johnson, Paula M Clements, Fiona E Benson, Larry H Thompson, Shunichi Takeda, Stephen C West, Keith W Caldecott.   

Abstract

The mechanisms by which the progression of eukaryotic replication forks is controlled after DNA damage are unclear. We have found that fork progression is slowed by cisplatin or UV treatment in intact vertebrate cells and in replication assays in vitro. Fork slowing is reduced or absent in irs1SF CHO cells and XRCC3(-/-) chicken DT40 cells, indicating that fork slowing is an active process that requires the homologous recombination protein XRCC3. The addition of purified human Rad51C-XRCC3 complex restores fork slowing in permeabilized XRCC3(-/-) cells. Moreover, the requirement for XRCC3 for fork slowing can be circumvented by addition of human Rad51. These data demonstrate that the recombination proteins XRCC3 and Rad51 cooperatively modulate the progression of replication forks on damaged vertebrate chromosomes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12718895     DOI: 10.1016/s1097-2765(03)00132-1

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  86 in total

1.  XRCC3 deficiency results in a defect in recombination and increased endoreduplication in human cells.

Authors:  Takashi Yoshihara; Mari Ishida; Aiko Kinomura; Mari Katsura; Takanori Tsuruga; Satoshi Tashiro; Toshimasa Asahara; Kiyoshi Miyagawa
Journal:  EMBO J       Date:  2004-01-29       Impact factor: 11.598

2.  Chk1 promotes replication fork progression by controlling replication initiation.

Authors:  Eva Petermann; Mick Woodcock; Thomas Helleday
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

3.  Discovery of a novel function for human Rad51: maintenance of the mitochondrial genome.

Authors:  Jay M Sage; Otto S Gildemeister; Kendall L Knight
Journal:  J Biol Chem       Date:  2010-04-22       Impact factor: 5.157

4.  Activation of new replication foci under conditions of replication stress.

Authors:  P Rybak; A Waligórska; Ł Bujnowicz; A Hoang; J W Dobrucki
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  Role of the Exocyst Complex Component Sec6/8 in Genomic Stability.

Authors:  Michael J Torres; Raj K Pandita; Ozlem Kulak; Rakesh Kumar; Etienne Formstecher; Nobuo Horikoshi; Kalpana Mujoo; Clayton R Hunt; Yingming Zhao; Lawrence Lum; Aubhishek Zaman; Charles Yeaman; Michael A White; Tej K Pandita
Journal:  Mol Cell Biol       Date:  2015-08-17       Impact factor: 4.272

6.  ASCIZ regulates lesion-specific Rad51 focus formation and apoptosis after methylating DNA damage.

Authors:  Carolyn J McNees; Lindus A Conlan; Nora Tenis; Jörg Heierhorst
Journal:  EMBO J       Date:  2005-06-02       Impact factor: 11.598

7.  Cdc2 tyrosine phosphorylation is not required for the S-phase DNA damage checkpoint in fission yeast.

Authors:  Naveen Kommajosyula; Nicholas Rhind
Journal:  Cell Cycle       Date:  2006-09-19       Impact factor: 4.534

8.  DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy.

Authors:  Angeline S Andrew; Margaret R Karagas; Heather H Nelson; Simonetta Guarrera; Silvia Polidoro; Sara Gamberini; Carlotta Sacerdote; Jason H Moore; Karl T Kelsey; Eugene Demidenko; Paolo Vineis; Giuseppe Matullo
Journal:  Hum Hered       Date:  2007-09-26       Impact factor: 0.444

9.  XRCC2 and XRCC3 regulate the balance between short- and long-tract gene conversions between sister chromatids.

Authors:  Ganesh Nagaraju; Andrea Hartlerode; Amy Kwok; Gurushankar Chandramouly; Ralph Scully
Journal:  Mol Cell Biol       Date:  2009-05-26       Impact factor: 4.272

10.  Role of the Saccharomyces cerevisiae Rad51 paralogs in sister chromatid recombination.

Authors:  Amy M Mozlin; Cindy W Fung; Lorraine S Symington
Journal:  Genetics       Date:  2008-01       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.